SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-013861
Filing Date
2019-09-09
Accepted
2019-09-09 16:01:24
Documents
71
Period of Report
2019-07-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 884632
2 image_001.jpg GRAPHIC 39687
3 ex10-1.htm EX-10.1 37588
4 ex31-1.htm EX-31.1 16146
5 ex31-2.htm EX-31.2 16152
6 ex32-1.htm EX-32.1 5697
7 ex32-2.htm EX-32.2 5775
  Complete submission text file 0001493152-19-013861.txt   5377690

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE adxs-20190731.xml EX-101.INS 1303606
9 XBRL SCHEMA FILE adxs-20190731.xsd EX-101.SCH 44830
10 XBRL CALCULATION FILE adxs-20190731_cal.xml EX-101.CAL 65581
11 XBRL DEFINITION FILE adxs-20190731_def.xml EX-101.DEF 158490
12 XBRL LABEL FILE adxs-20190731_lab.xml EX-101.LAB 332680
13 XBRL PRESENTATION FILE adxs-20190731_pre.xml EX-101.PRE 269456
Mailing Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-36138 | Film No.: 191083111
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1